TNAX Biopharma株式会社
TNAX Biopharma is a developer of pharmaceuticals drugs intended to improve the quality of life of patients.
TNAX Biopharma株式会社 is a business in medtech based in Tokyo, Japan.
Profile
"TNAX Biopharma is a Medtech company dedicated to discovering valuable pharmaceutical drugs that target interactions between immune receptors and their ligands, aiming to enhance the quality of life for patients with challenging diseases. Focused on addressing unmet medical needs in patients with difficult-to-treat conditions, TNAX Biopharma specializes in the development and commercialization of innovative antibody therapies. Founded by Dr. Akira Shibutani, a renowned scientist who discovered unique immune receptors and their ligands with crucial roles in immunity and inflammation, TNAX Biopharma collaborates with Tsukuba University to leverage exclusive intellectual property rights for potential therapeutic targets. Through groundbreaking drug discovery and strategic partnerships, TNAX continues to contribute to society by providing truly valuable treatments to patients worldwide."
Within the medtech space, the company focuses on its core offering rather than a broad product line.
The business is associated with Tokyo, Japan.
The company is listed at the Plug and Play portfolio startup stage of development.
| Sector | Medtech |
|---|---|
| Headquarters | Tokyo, Japan |
| Country | Japan |
| Stage | Plug and Play portfolio startup |
Website: tnaxbio.com
Browse related
Create a free account